Synergistic Interactions between Repeats in Tau Protein and Aβ Amyloids May Be Responsible for Accelerated Aggregation via Polymorphic States
暂无分享,去创建一个
Ruth Nussinov | Buyong Ma | R. Nussinov | B. Ma | Y. Miller | Yifat Miller
[1] J. Kuret,et al. In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants. , 2000, Biochemistry.
[2] J. Ávila,et al. Polymerization of tau peptides into fibrillar structures. The effect of FTDP‐17 mutations , 1999, FEBS letters.
[3] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[4] Laxmikant V. Kale,et al. NAMD2: Greater Scalability for Parallel Molecular Dynamics , 1999 .
[5] W. Markesbery,et al. Impaired Proteasome Function in Alzheimer's Disease , 2000, Journal of neurochemistry.
[6] I. Mook‐Jung,et al. Amyloid peptide attenuates the proteasome activity in neuronal cells , 2005, Mechanisms of Ageing and Development.
[7] R. Riek,et al. 3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .
[8] B. Yankner,et al. β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding , 1995, Neuron.
[9] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[10] Ruth Nussinov,et al. Hollow core of Alzheimer’s Aβ42 amyloid observed by cryoEM is relevant at physiological pH , 2010, Proceedings of the National Academy of Sciences.
[11] R. Crowther,et al. Effects of frontotemporal dementia FTDP‐17 mutations on heparin‐induced assembly of tau filaments , 1999, FEBS letters.
[12] Da-Wei Li,et al. Formation and Growth of Oligomers: A Monte Carlo Study of an Amyloid Tau Fragment , 2008, PLoS Comput. Biol..
[13] Ruth Nussinov,et al. The unique Alzheimer's β-amyloid triangular fibril has a cavity along the fibril axis under physiological conditions. , 2011, Journal of the American Chemical Society.
[14] V. Muñoz,et al. Alpha-helix structure in Alzheimer's disease aggregates of tau-protein. , 2002, Biochemistry.
[15] Christian Griesinger,et al. Structural Polymorphism of 441-Residue Tau at Single Residue Resolution , 2009, PLoS biology.
[16] Daniel J. Muller,et al. Human Tau Isoforms Assemble into Ribbon-like Fibrils That Display Polymorphic Structure and Stability* , 2010, The Journal of Biological Chemistry.
[17] M. Hutton,et al. Missense tau mutations identified in FTDP-17 have a small effect on tau–microtubule interactions , 2000, Brain Research.
[18] D. Selkoe,et al. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. , 2003, Annual review of pharmacology and toxicology.
[19] Li-Huei Tsai,et al. Aberrant Cdk5 Activation by p25 Triggers Pathological Events Leading to Neurodegeneration and Neurofibrillary Tangles , 2003, Neuron.
[20] Jürgen Götz,et al. Dissecting Toxicity of Tau and β-Amyloid , 2010, Neurodegenerative Diseases.
[21] Federico Gago,et al. Phosphorylation modulates the alpha-helical structure and polymerization of a peptide from the third tau microtubule-binding repeat. , 2005, Biochimica et biophysica acta.
[22] D. Kirschner,et al. The Formation of Straight and Twisted Filaments from Short Tau Peptides* , 2004, Journal of Biological Chemistry.
[23] R. Kayed,et al. Preparation and characterization of neurotoxic tau oligomers. , 2010, Biochemistry.
[24] K. Tomoo,et al. Amphipathic helical behavior of the third repeat fragment in the tau microtubule-binding domain, studied by (1)H NMR spectroscopy. , 2002, Biochemical and biophysical research communications.
[25] R. Ravid,et al. Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.
[26] E. Mandelkow,et al. Mutations of Tau Protein in Frontotemporal Dementia Promote Aggregation of Paired Helical Filaments by Enhancing Local β-Structure* , 2001, The Journal of Biological Chemistry.
[27] G. Ciccotti,et al. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .
[28] C. Brooks,et al. Novel generalized Born methods , 2002 .
[29] G. Schellenberg,et al. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[30] Ruth Nussinov,et al. Zinc ions promote Alzheimer Aβ aggregation via population shift of polymorphic states , 2010, Proceedings of the National Academy of Sciences.
[31] T. Darden,et al. A smooth particle mesh Ewald method , 1995 .
[32] E. Mandelkow,et al. Tau in Alzheimer's disease. , 1998, Trends in cell biology.
[33] M. Karplus,et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .
[34] R. Langen,et al. Side Chain-dependent Stacking Modulates Tau Filament Structure* , 2006, Journal of Biological Chemistry.
[35] F. LaFerla,et al. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease , 2003, Neurobiology of Aging.
[36] F. LaFerla,et al. Pathways by which Abeta facilitates tau pathology. , 2006, Current Alzheimer research.
[37] M. Mattson,et al. Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.
[38] Martin von Bergen,et al. Tau aggregation is driven by a transition from random coil to beta sheet structure. , 2005, Biochimica et biophysica acta.
[39] Charles L. Brooks,et al. New analytic approximation to the standard molecular volume definition and its application to generalized Born calculations , 2003, J. Comput. Chem..
[40] John X. Morris,et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.
[41] R. Nitsch,et al. Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.
[42] S. Radford,et al. Stacked Sets of Parallel, In-register β-Strands of β2-Microglobulin in Amyloid Fibrils Revealed by Site-directed Spin Labeling and Chemical Labeling* , 2010, The Journal of Biological Chemistry.
[43] J. Trojanowski,et al. Characterization of tau fibrillization in vitro , 2010, Alzheimer's & Dementia.
[44] Ruth Nussinov,et al. Molecular-level examination of Cu2+ binding structure for amyloid fibrils of 40-residue Alzheimer's β by solid-state NMR spectroscopy. , 2011, Journal of the American Chemical Society.
[45] R. Nussinov,et al. Polymorphism of Alzheimer's Abeta17-42 (p3) oligomers: the importance of the turn location and its conformation. , 2009, Biophysical journal.
[46] Christian Griesinger,et al. Sites of Tau Important for Aggregation Populate β-Structure and Bind to Microtubules and Polyanions* , 2005, Journal of Biological Chemistry.
[47] F. LaFerla. Pathways linking Abeta and tau pathologies. , 2010, Biochemical Society transactions.
[48] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[49] R. Maccioni,et al. Inhibition of tau phosphorylating protein kinase cdk5 prevents β‐amyloid‐induced neuronal death , 1999, FEBS letters.
[50] Alexander D. MacKerell,et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.
[51] Gerd Krause,et al. General structural motifs of amyloid protofilaments , 2006, Proceedings of the National Academy of Sciences.
[52] Xiaomin Song,et al. Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice , 2009, Proceedings of the National Academy of Sciences.
[53] Michel Goedert,et al. Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-β structure , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[54] Tetsuaki Arai,et al. Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[55] Hyonchol Kim,et al. Granular tau oligomers as intermediates of tau filaments. , 2007, Biochemistry.
[56] K. Imahori,et al. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[57] K. Tomoo,et al. Different associational and conformational behaviors between the second and third repeat fragments in the tau microtubule-binding domain. , 2004, European journal of biochemistry.
[58] J. Götz,et al. Soluble Beta-Amyloid Leads to Mitochondrial Defects in Amyloid Precursor Protein and Tau Transgenic Mice , 2008, Neurodegenerative Diseases.
[59] J. Ávila,et al. Tau aggregation followed by atomic force microscopy and surface plasmon resonance, and single molecule tau-tau interaction probed by atomic force spectroscopy. , 2009, Journal of Alzheimer's disease : JAD.
[60] Michael W. Mahoney,et al. A five-site model for liquid water and the reproduction of the density anomaly by rigid, nonpolarizable potential functions , 2000 .
[61] A. Erisir,et al. Tau-dependent microtubule disassembly initiated by prefibrillar β-amyloid , 2006, The Journal of cell biology.
[62] R. Riek,et al. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[63] Ralf Langen,et al. Template-assisted filament growth by parallel stacking of tau. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[64] Fabrizio Chiti,et al. A causative link between the structure of aberrant protein oligomers and their toxicity. , 2010, Nature chemical biology.
[65] B. Brooks,et al. Constant pressure molecular dynamics simulation: The Langevin piston method , 1995 .
[66] F. Dahlquist,et al. A soluble oligomer of tau associated with fiber formation analyzed by NMR. , 2008, Biochemistry.
[67] A. Caccamo,et al. Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aβ oligomers accumulation , 2010, Molecular Neurodegeneration.
[68] D. Eliezer,et al. Residual structure in the repeat domain of tau: echoes of microtubule binding and paired helical filament formation. , 2005, Biochemistry.
[69] David Eisenberg,et al. Identifying the amylome, proteins capable of forming amyloid-like fibrils , 2010, Proceedings of the National Academy of Sciences.
[70] J. Hardy,et al. Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.
[71] M. Hutton,et al. Accelerated filament formation from tau protein with specific FTDP‐17 missense mutations , 1999, FEBS letters.
[72] Christian Griesinger,et al. The “Jaws” of the Tau-Microtubule Interaction* , 2007, Journal of Biological Chemistry.
[73] E. Mandelkow,et al. Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. , 2000, Biochemistry.
[74] M. Klein,et al. Constant pressure molecular dynamics algorithms , 1994 .
[75] W. Müller,et al. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease , 2006, Experimental Gerontology.
[76] R. Tycko,et al. Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.
[77] C. L. Teoh,et al. Visualization of polymorphism in apolipoprotein C-II amyloid fibrils. , 2011, Journal of biochemistry.
[78] I. Grundke‐Iqbal,et al. Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains , 1994, FEBS letters.
[79] E. Mandelkow,et al. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[80] R. Nussinov,et al. Polymorphism in Alzheimer Aβ Amyloid Organization Reflects Conformational Selection in a Rugged Energy Landscape , 2010, Chemical reviews.